verapamil has been researched along with phenytoin in 128 studies
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 71 (55.47) | 18.7374 |
1990's | 11 (8.59) | 18.2507 |
2000's | 18 (14.06) | 29.6817 |
2010's | 26 (20.31) | 24.3611 |
2020's | 2 (1.56) | 2.80 |
Authors | Studies |
---|---|
Creveling, CR; Daly, JW; Lewandowski, GA; McNeal, ET | 1 |
Topliss, JG; Yoshida, F | 1 |
Anger, T; Madge, DJ; Mulla, M; Riddall, D | 1 |
Alvarez-Pedraglio, A; Colmenarejo, G; Lavandera, JL | 1 |
Bruno-Blanch, L; Gálvez, J; García-Domenech, R | 1 |
Du, LP; Li, MY; Tsai, KC; Xia, L; You, QD | 1 |
Caron, G; Ermondi, G | 1 |
Benz, RD; Contrera, JF; Kruhlak, NL; Matthews, EJ; Weaver, JL | 1 |
Baltes, S; Fedrowitz, M; Gastens, AM; Kaever, V; Löscher, W; Potschka, H | 1 |
Akamatsu, M; Fujikawa, M; Nakao, K; Shimizu, R | 1 |
Abraham, MH; Acree, WE; Ibrahim, A | 1 |
Artursson, P; Bergström, CA; Hoogstraate, J; Matsson, P; Norinder, U; Pedersen, JM | 1 |
Ahlin, G; Artursson, P; Bergström, CA; Gustavsson, L; Karlsson, J; Larsson, R; Matsson, P; Norinder, U; Pedersen, JM | 1 |
Chen, L; He, Z; Li, H; Liu, J; Liu, X; Sui, X; Sun, J; Wang, Y; Zhang, W | 1 |
Du-Cuny, L; Mash, EA; Meuillet, EJ; Moses, S; Powis, G; Song, Z; Zhang, S | 1 |
Barnes, JC; Bradley, P; Day, NC; Fourches, D; Reed, JZ; Tropsha, A | 1 |
Campillo, NE; Guerra, A; Páez, JA | 1 |
Chang, G; El-Kattan, A; Miller, HR; Obach, RS; Rotter, C; Steyn, SJ; Troutman, MD; Varma, MV | 1 |
García-Mera, X; González-Díaz, H; Prado-Prado, FJ | 1 |
Gozalbes, R; Pineda-Lucena, A | 1 |
Akamatsu, M | 1 |
Sen, S; Sinha, N | 1 |
Cooper, J; Cui, Y; Fink, M; Gavaghan, DJ; Heath, BM; McMahon, NC; Mirams, GR; Noble, D; Sher, A | 1 |
Annand, R; Gozalbes, R; Jacewicz, M; Pineda-Lucena, A; Tsaioun, K | 1 |
Honda, K; Izumi, T; Miyaji, Y; Nakayama, S; Okazaki, O; Okudaira, N; Shiosakai, K; Sugiyama, D; Suzuki, W; Takakusa, H; Watanabe, A | 1 |
Chen, M; Fang, H; Liu, Z; Shi, Q; Tong, W; Vijay, V | 1 |
Barber, S; Dew, TP; Farrell, TL; Poquet, L; Williamson, G | 1 |
Artursson, P; Haglund, U; Karlgren, M; Kimoto, E; Lai, Y; Norinder, U; Vildhede, A; Wisniewski, JR | 1 |
Fijorek, K; Glinka, A; Mendyk, A; Polak, S; Wiśniowska, B | 1 |
Brown, AM; Bruening-Wright, A; Kramer, J; Kuryshev, YA; Myatt, G; Obejero-Paz, CA; Verducci, JS | 1 |
Brouillette, WJ; Brown, GB; Zha, C | 1 |
Chen, M; Hu, C; Suzuki, A; Thakkar, S; Tong, W; Yu, K | 1 |
Bloomer, WD; Papadopoulou, MV; Rosenzweig, HS | 1 |
Julian, DG | 1 |
Theisen, K | 1 |
Donaldson, RM | 1 |
Brochier, M; Fauchier, JP | 1 |
Dretchen, KL; Raines, A; Standaert, FG | 1 |
Bender, F | 2 |
Merx, W | 1 |
Watson, EL | 1 |
Anderson, JL; Harrison, DC; Meffin, PJ; Winkle, RA | 1 |
Doenecke, VP | 1 |
Hepp, A; Raff, U | 1 |
Loogen, F | 1 |
Doenecke, P | 1 |
Chalfie, M; Hoadley, D; Pastan, S; Perlman, RL | 1 |
Araú, A; Bonhorst, D; Bordalo, A; De Azevedo, JG; Ferreira, M; Ferreira, R; Inês, L; Lacximy, I; Longo, A; Luis Martins, J; Melo, M; Nunes Diogo, A; Ribeiro, C; Sanches, C; Teixeira, J | 1 |
Steinbach, K | 1 |
Arnsdorf, MF | 1 |
Akaike, N; Kameda, H; Kataoka, M; Takahashi, K; Ueno, S | 1 |
De Sarro, A; De Sarro, GB; Nistico', G; Trimarchi, GR | 1 |
Hopf, R; Kaltenbach, M; Kirsten, R; Nelson, K; Rietbrock, S; Woodcock, BG | 1 |
Besser, GM; Grossman, A; Rees, LH; Tsagarakis, S | 1 |
Bahls, FH; Ozuna, J; Ritchie, DE | 1 |
Kano, M; Kudo, Y; Suzuki, N; Takagi, H; Tanakadate, A; Yoshioka, T | 1 |
Lantos, J; Sárosi, I; Temes, G; Török, B | 1 |
Carpenter, CL; Greenberg, DA; Messing, RO | 1 |
Keefe, DL; Miura, D; Somberg, JC | 1 |
Anderson, RE; Meyer, FB; Sharbrough, FW; Sundt, TM; Tally, PW; Yaksh, TL | 1 |
Dretchen, KL; Henderson, TR; Raines, A | 1 |
Eisenberg, M; Kern, IB; Willis, S | 1 |
Antman, EM; Smith, TW | 1 |
Somberg, J | 1 |
Baciewicz, AM; Bekemeyer, WB; Self, TH | 1 |
Fredholm, BB; Hänström, L; Lerner, U | 1 |
Imanaka, S; Ito, K; Matsuda, S; Matsuoka, T; Okada, Y | 1 |
Andersson, KE; Wettrell, G | 1 |
Huang, SK; Marcus, FI | 1 |
Anderson, RE; Ots, ME; Sundt, TM; Yaksh, TL | 1 |
Balazs, T; Ehrreich, SJ; el-Hage, AN; Johnson, GL | 1 |
Hashimoto, K; Imai, S; Shibuya, T | 1 |
Cucchi, G; Giustiniani, S; Robustelli, F | 1 |
Bursztein, S; Heifetz, M; Weinbroum, A | 1 |
Diedrich, R; Hardewig, A | 1 |
Kaufmann, G | 1 |
Clodi, PH; Hartl, O | 1 |
Chatillon, J | 1 |
Gleichmann, U; Loogen, F; Seipel, L | 2 |
Hauswirth, O; Singh, BN | 1 |
Menner, K; Raugenburg, HW; Weigand, KH | 1 |
Heeg, E; Reuter, N; Steiger, H | 1 |
Strubelt, O; Zetler, G | 1 |
Andresen, T; Hardewig, A; Thormann, J | 1 |
Hensel, G | 1 |
Bleifeld, W; Effert, S; Merx, W | 1 |
Heeg, E; Reuter, N | 1 |
Collignon, P; Kulbertus, H | 1 |
Both, A; Breithardt, G; Gleichmann, U; Loogen, F; Seipel, L | 1 |
Zeh, E | 1 |
Boissier, JR; Giudicelli, JF; Larno, S; Witchitz, S | 1 |
Frey, J; Schüffler, J | 1 |
Schollmeyer, P | 1 |
Büchner, M; Effert, S; Grosse-Brockhoff, F | 1 |
Elkayam, U; Frishman, W; Rotmensch, HH | 1 |
Ali, C; Holt, DW; Volans, GN | 1 |
Jahrmärker, H; Theisen, K | 1 |
Erlichman, J; Fleckman, A; Fleischer, N; Schubart, UK | 1 |
Rosen, MR; Wit, AL | 1 |
Halawa, B | 1 |
Hashimoto, K; Imai, S; Satoh, H; Shibuya, T | 2 |
Dreifus, LS; Morganroth, J | 1 |
De Cosmo, G; Foti, A; Proietti, R; Sabato, AF | 1 |
Bittar, EE; Nwoga, J | 1 |
Gillette, PC | 1 |
Akera, T; Brody, TM; Brown, BS | 1 |
Lazarus, LH; Spracklen, FH | 1 |
Chung, DH; Cooper, CW; Ishizuka, J; Rajaraman, S; Sato, K; Thompson, JC; Townsend, CM; Tsuchiya, T; Uchida, T | 1 |
Beck, WT; Schuetz, EG; Schuetz, JD | 1 |
Desai, P; Silver, JG | 1 |
Fisher, JD; Hallidie-Smith, KA; Krikler, D | 1 |
Manley, SW; Mitchell, AM; Mortimer, RH; Powell, KA | 1 |
Akimoto, Y; Fujii, A; Matsumoto, H; Noji, I | 1 |
Marsh, E; O'Callaghan, P; Smith, P | 1 |
Liu, HY; Liu, X; Liu, XD; Liu, YC; Wang, GJ; Xie, L; Yang, HW; Zhang, DM | 1 |
Baum, L; Kwan, P; Zhang, C; Zuo, Z | 1 |
Bedada, SK; Ganji, D; Neerati, P | 1 |
Luna-Munguia, H; Orozco-Suarez, S; Rocha, L | 1 |
Ding, AW; Duan, JA; Lü, GH; Lu, WJ; Ma, HY; You, FQ; Zhou, J | 1 |
Alvariza, S; Fagiolino, P; Orozco Suárez, S; Rocha, L; Rosillo de la Torre, A; Vázquez, M | 1 |
Chen, Y; Ma, A; Wang, C; Yuan, W | 1 |
Ohtsuki, S; Terasaki, T; Uchida, Y | 1 |
Chen, SL; Fan, Q; Ma, H; Zhang, C | 1 |
Alves, G; Falcão, A; Ferreira, A; Fortuna, A; Meirinho, S; Rodrigues, M | 1 |
Ito, S; Iwamoto, K; Kamimura, H; Mizunaga, M; Nakayama, K; Negoro, T; Nishiwaki, M; Nomura, Y; Suemizu, H; Yamazaki, H; Yoneda, N | 1 |
18 review(s) available for verapamil and phenytoin
Article | Year |
---|---|
Medicinal chemistry of neuronal voltage-gated sodium channel blockers.
Topics: Amyotrophic Lateral Sclerosis; Analgesics; Anticonvulsants; Epilepsy; Humans; Ion Channel Gating; Models, Molecular; Mutation; Nerve Tissue Proteins; Neuroprotective Agents; Protein Binding; Sodium Channel Blockers; Sodium Channels; Stroke | 2001 |
DILIrank: the largest reference drug list ranked by the risk for developing drug-induced liver injury in humans.
Topics: Chemical and Drug Induced Liver Injury; Databases, Factual; Drug Labeling; Humans; Pharmaceutical Preparations; Risk | 2016 |
Cardiac arrhythmias - a short review.
Topics: Adrenergic beta-Agonists; Arrhythmias, Cardiac; Digitalis Glycosides; Electric Countershock; Electrocardiography; Humans; Lidocaine; Mexiletine; Pacemaker, Artificial; Phenytoin; Procainamide; Quinidine; Verapamil | 1976 |
The treatment of ventricular rhythm disturbances.
Topics: Adrenergic beta-Antagonists; Anti-Arrhythmia Agents; Arrhythmias, Cardiac; Cardiac Complexes, Premature; Disopyramide; Electric Countershock; Electric Stimulation; Electrocardiography; Exercise Test; Flecainide; Heart Ventricles; Humans; Lidocaine; Phenytoin; Piperidines; Procainamide; Quinidine; Risk; Tachycardia; Tocainide; United States; Ventricular Fibrillation; Verapamil | 1986 |
Digitalis toxicity.
Topics: Adrenergic beta-Antagonists; Arrhythmias, Cardiac; Biological Availability; Carotid Sinus; Digitalis Glycosides; Drug Interactions; Electric Countershock; Heart; Heart Conduction System; Humans; Kinetics; Lidocaine; Parasympathetic Nervous System; Phenytoin; Potassium; Procainamide; Quinidine; Sympathetic Nervous System; Verapamil | 1985 |
Antiarrhythmic drug therapy. Recent advances and current status.
Topics: Adrenergic beta-Antagonists; Ajmaline; Amiodarone; Anilides; Anti-Arrhythmia Agents; Aprindine; Arrhythmias, Cardiac; Benzeneacetamides; Bepridil; Bethanidine; Bretylium Tosylate; Disopyramide; Drug Administration Schedule; Encainide; Flecainide; Heart Conduction System; Humans; Imidazoles; Lidocaine; Mexiletine; Moricizine; Myocardial Contraction; Phenothiazines; Phenytoin; Piperidines; Procainamide; Propafenone; Propiophenones; Pyrrolidines; Quinidine; Tocainide; Verapamil | 1985 |
Cardiovascular drugs. I: Antidysrhythmic drugs.
Topics: Ajmaline; Amiodarone; Anti-Arrhythmia Agents; Cardiovascular Agents; Disopyramide; Drug Interactions; Humans; Kinetics; Lidocaine; Mexiletine; Phenytoin; Procainamide; Tocainide; Verapamil | 1986 |
Antiarrhythmic drug therapy of ventricular arrhythmias.
Topics: Amiodarone; Anti-Arrhythmia Agents; Arrhythmias, Cardiac; Bretylium Tosylate; Disopyramide; Flecainide; Heart Ventricles; Humans; Lidocaine; Mexiletine; Moricizine; Phenothiazines; Phenytoin; Piperidines; Procainamide; Propafenone; Propiophenones; Quinidine; Sotalol; Tocainide; Verapamil | 1986 |
[Anti-arrhythmia agents].
Topics: Action Potentials; Ajmaline; Anti-Arrhythmia Agents; Arrhythmias, Cardiac; Atrial Fibrillation; Atrial Flutter; Cardiac Complexes, Premature; Heart; Heart Conduction System; Humans; Lidocaine; Phenytoin; Practolol; Procainamide; Quinidine; Sparteine; Ventricular Fibrillation; Verapamil | 1974 |
Comparative mechanisms of action of antiarrhythmic drugs.
Topics: Action Potentials; Adrenergic beta-Antagonists; Anti-Arrhythmia Agents; Arrhythmias, Cardiac; Benzofurans; Benzyl Compounds; Bretylium Compounds; Calcium; Carbamazepine; Chemical Phenomena; Chemistry; Diethylamines; Disopyramide; Heart; Humans; Imidazoles; Iodobenzoates; Lidocaine; Membrane Potentials; Phenyl Ethers; Phenytoin; Procainamide; Propylamines; Quinidine; Verapamil | 1974 |
[Modern treatment of cardiac arrhythmias].
Topics: Adrenergic beta-Antagonists; Arrhythmias, Cardiac; Bradycardia; Cell Membrane Permeability; Digitalis Glycosides; Electric Countershock; Heart; Heart Block; Humans; Hypoxia; Magnesium; Metaproterenol; Myocardium; Pacemaker, Artificial; Phenytoin; Phytotherapy; Plants, Medicinal; Potassium; Quinidine; Rauwolfia; Sodium; Sparteine; Tachycardia; Ventricular Fibrillation; Verapamil | 1971 |
[Bundle of His ECG].
Topics: Ajmaline; Bundle of His; Cardiac Catheterization; Digitalis; Electrocardiography; Heart Block; Heart Conduction System; Humans; Phenytoin; Plants, Medicinal; Plants, Toxic; Verapamil | 1974 |
Antiarrhythmic drug therapy during pregnancy.
Topics: Adrenergic beta-Antagonists; Anti-Arrhythmia Agents; Arrhythmias, Cardiac; Breast Feeding; Digitalis Glycosides; Disopyramide; Female; Fetus; Humans; Infant, Newborn; Lidocaine; Maternal-Fetal Exchange; Phenytoin; Pregnancy; Pregnancy Complications, Cardiovascular; Procainamide; Quinidine; Tachycardia; Verapamil | 1983 |
[Medical treatment of extrasystole and tachycardia (author's transl)].
Topics: Action Potentials; Ajmaline; Amiodarone; Anti-Arrhythmia Agents; Bretylium Compounds; Calcium; Cardiac Complexes, Premature; Digoxin; Disopyramide; Electrophysiology; Humans; Lidocaine; Mexiletine; Myocardial Infarction; Phenytoin; Quinidine; Tachycardia; Tachycardia, Paroxysmal; Verapamil | 1980 |
Electropharmacology of antiarrhythmic drugs.
Topics: Action Potentials; Amiodarone; Anti-Arrhythmia Agents; Aprindine; Arrhythmias, Cardiac; Disopyramide; Electric Conductivity; Heart Atria; Heart Ventricles; Humans; Lidocaine; Membrane Potentials; Mexiletine; Moricizine; Phenothiazines; Phenytoin; Procainamide; Propranolol; Purkinje Fibers; Quinidine; Tocainide; Verapamil | 1983 |
Antiarrhythmic agents and their use in therapy.
Topics: Acebutolol; Animals; Anti-Arrhythmia Agents; Digitalis Glycosides; Disopyramide; Humans; Lidocaine; Oxytocin; Phenytoin; Procainamide; Propranolol; Quinidine; Verapamil | 1980 |
Drug-induced gingival enlargements.
Topics: Anticonvulsants; Calcium Channel Blockers; Cyclosporine; Gingival Overgrowth; Humans; Immunosuppressive Agents; Nifedipine; Phenytoin; Verapamil | 1998 |
The humble electrocardiogram.
Topics: Anticonvulsants; Arrhythmias, Cardiac; Brain Diseases; Electrocardiography; Heart; Humans; Nervous System Diseases; Neurology; Phenytoin; Unconsciousness; Vasodilator Agents; Verapamil | 2008 |
110 other study(ies) available for verapamil and phenytoin
Article | Year |
---|---|
[3H]Batrachotoxinin A 20 alpha-benzoate binding to voltage-sensitive sodium channels: a rapid and quantitative assay for local anesthetic activity in a variety of drugs.
Topics: Adrenergic alpha-Antagonists; Adrenergic beta-Antagonists; Anesthetics, Local; Animals; Batrachotoxins; Calcium Channel Blockers; Cyclic AMP; Guinea Pigs; Histamine H1 Antagonists; In Vitro Techniques; Ion Channels; Neurotoxins; Sodium; Tranquilizing Agents; Tritium | 1985 |
QSAR model for drug human oral bioavailability.
Topics: Administration, Oral; Biological Availability; Humans; Models, Biological; Models, Molecular; Pharmaceutical Preparations; Pharmacokinetics; Structure-Activity Relationship | 2000 |
Cheminformatic models to predict binding affinities to human serum albumin.
Topics: Adrenergic beta-Antagonists; Antidepressive Agents, Tricyclic; Chromatography, Affinity; Cyclooxygenase Inhibitors; Databases, Factual; Humans; Hydrophobic and Hydrophilic Interactions; Penicillins; Pharmaceutical Preparations; Protein Binding; Quantitative Structure-Activity Relationship; Reproducibility of Results; Serum Albumin; Steroids | 2001 |
Topological virtual screening: a way to find new anticonvulsant drugs from chemical diversity.
Topics: Anticonvulsants; Computer Simulation; Databases, Factual; Discriminant Analysis; Drug Design; Molecular Structure; Quantitative Structure-Activity Relationship | 2003 |
The pharmacophore hypotheses of I(Kr) potassium channel blockers: novel class III antiarrhythmic agents.
Topics: Anti-Arrhythmia Agents; Models, Biological; Models, Molecular; Potassium Channel Blockers; Potassium Channels; Quantitative Structure-Activity Relationship; Technology, Pharmaceutical | 2004 |
Calculating virtual log P in the alkane/water system (log P(N)(alk)) and its derived parameters deltalog P(N)(oct-alk) and log D(pH)(alk).
Topics: 1-Octanol; Alkanes; Hydrogen-Ion Concentration; Least-Squares Analysis; Mathematics; Models, Chemical; Models, Molecular; Solvents; Water | 2005 |
Assessment of the health effects of chemicals in humans: II. Construction of an adverse effects database for QSAR modeling.
Topics: Adverse Drug Reaction Reporting Systems; Artificial Intelligence; Computers; Databases, Factual; Drug Prescriptions; Drug-Related Side Effects and Adverse Reactions; Endpoint Determination; Models, Molecular; Quantitative Structure-Activity Relationship; Software; United States; United States Food and Drug Administration | 2004 |
Differences in the transport of the antiepileptic drugs phenytoin, levetiracetam and carbamazepine by human and mouse P-glycoprotein.
Topics: Analysis of Variance; Animals; Anticonvulsants; ATP Binding Cassette Transporter, Subfamily B, Member 1; ATP-Binding Cassette Transporters; Biological Transport; Carbamazepine; Cell Line; Cyclosporine; Dogs; Dose-Response Relationship, Drug; Drug Interactions; Enzyme Inhibitors; Gene Expression; Humans; Levetiracetam; Mice; Phenytoin; Piracetam; Transfection | 2007 |
QSAR study on permeability of hydrophobic compounds with artificial membranes.
Topics: Biological Transport; Caco-2 Cells; Drug Evaluation, Preclinical; Humans; Hydrophobic and Hydrophilic Interactions; Membranes, Artificial; Permeability; Pharmaceutical Preparations; Quantitative Structure-Activity Relationship | 2007 |
Air to lung partition coefficients for volatile organic compounds and blood to lung partition coefficients for volatile organic compounds and drugs.
Topics: Air; Animals; Humans; Lung; Organic Chemicals; Probability; Rats; Tissue Distribution; Volatilization | 2008 |
Prediction and identification of drug interactions with the human ATP-binding cassette transporter multidrug-resistance associated protein 2 (MRP2; ABCC2).
Topics: Administration, Oral; Animals; Antineoplastic Agents; Antipsychotic Agents; Antiviral Agents; ATP Binding Cassette Transporter, Subfamily B; ATP Binding Cassette Transporter, Subfamily B, Member 1; ATP Binding Cassette Transporter, Subfamily G, Member 2; ATP-Binding Cassette Transporters; Biological Transport; Cell Line; Computer Simulation; Cytochrome P-450 Enzyme System; Drug-Related Side Effects and Adverse Reactions; Estradiol; Humans; Insecta; Liver; Models, Molecular; Multidrug Resistance-Associated Protein 2; Multidrug Resistance-Associated Proteins; Neoplasm Proteins; Pharmaceutical Preparations; Pharmacology; Structure-Activity Relationship | 2008 |
Structural requirements for drug inhibition of the liver specific human organic cation transport protein 1.
Topics: Cell Line; Computer Simulation; Drug Design; Gene Expression Profiling; Humans; Hydrogen Bonding; Liver; Molecular Weight; Organic Cation Transporter 1; Pharmaceutical Preparations; Predictive Value of Tests; Reverse Transcriptase Polymerase Chain Reaction; RNA, Messenger; Structure-Activity Relationship | 2008 |
Prediction of volume of distribution values in human using immobilized artificial membrane partitioning coefficients, the fraction of compound ionized and plasma protein binding data.
Topics: Blood Proteins; Chemistry, Physical; Computer Simulation; Humans; Membranes, Artificial; Models, Biological; Pharmaceutical Preparations; Protein Binding; Tissue Distribution | 2009 |
Computational modeling of novel inhibitors targeting the Akt pleckstrin homology domain.
Topics: Antineoplastic Agents; Blood Proteins; Caco-2 Cells; Cell Membrane Permeability; Computer Simulation; Drug Discovery; Drug Screening Assays, Antitumor; Humans; Models, Molecular; Phosphoproteins; Protein Binding; Protein Kinase Inhibitors; Protein Structure, Tertiary; Proto-Oncogene Proteins c-akt; Quantitative Structure-Activity Relationship | 2009 |
Cheminformatics analysis of assertions mined from literature that describe drug-induced liver injury in different species.
Topics: Animals; Chemical and Drug Induced Liver Injury; Cluster Analysis; Databases, Factual; Humans; MEDLINE; Mice; Models, Chemical; Molecular Conformation; Quantitative Structure-Activity Relationship | 2010 |
Neural computational prediction of oral drug absorption based on CODES 2D descriptors.
Topics: Administration, Oral; Humans; Models, Chemical; Neural Networks, Computer; Permeability; Quantitative Structure-Activity Relationship; Technology, Pharmaceutical | 2010 |
Physicochemical space for optimum oral bioavailability: contribution of human intestinal absorption and first-pass elimination.
Topics: Administration, Oral; Biological Availability; Humans; Intestinal Absorption; Pharmaceutical Preparations | 2010 |
Multi-target spectral moment QSAR versus ANN for antiparasitic drugs against different parasite species.
Topics: Antiparasitic Agents; Molecular Structure; Neural Networks, Computer; Parasitic Diseases; Quantitative Structure-Activity Relationship; Species Specificity; Thermodynamics | 2010 |
QSAR-based solubility model for drug-like compounds.
Topics: Databases, Factual; Models, Molecular; Pharmaceutical Preparations; Quantitative Structure-Activity Relationship; Solubility; Water | 2010 |
Importance of physicochemical properties for the design of new pesticides.
Topics: Anabasine; Animals; Biological Availability; Cell Membrane Permeability; Chemical Phenomena; Drug Design; Humans; Imidazoles; Insecticides; Neonicotinoids; Nitro Compounds; Pesticides; Quantitative Structure-Activity Relationship; Receptors, Nicotinic | 2011 |
Predicting hERG activities of compounds from their 3D structures: development and evaluation of a global descriptors based QSAR model.
Topics: Computer Simulation; Ether-A-Go-Go Potassium Channels; Humans; Molecular Structure; Organic Chemicals; Quantitative Structure-Activity Relationship | 2011 |
Simulation of multiple ion channel block provides improved early prediction of compounds' clinical torsadogenic risk.
Topics: Action Potentials; Animals; Calcium Channel Blockers; Calcium Channels, L-Type; Computer Simulation; Dogs; Dose-Response Relationship, Drug; ERG1 Potassium Channel; Ether-A-Go-Go Potassium Channels; Guinea Pigs; HEK293 Cells; Humans; Ion Channels; Kinetics; Models, Cardiovascular; NAV1.5 Voltage-Gated Sodium Channel; Patch-Clamp Techniques; Potassium Channel Blockers; Rabbits; Risk Assessment; Risk Factors; Sodium Channel Blockers; Sodium Channels; Torsades de Pointes; Transfection | 2011 |
QSAR-based permeability model for drug-like compounds.
Topics: Caco-2 Cells; Cell Membrane Permeability; Drug Discovery; Humans; Pharmaceutical Preparations; Pharmacokinetics; Quantitative Structure-Activity Relationship | 2011 |
Combination of GSH trapping and time-dependent inhibition assays as a predictive method of drugs generating highly reactive metabolites.
Topics: Glutathione; Pharmacology; Sulfur Radioisotopes | 2011 |
FDA-approved drug labeling for the study of drug-induced liver injury.
Topics: Animals; Benchmarking; Biomarkers, Pharmacological; Chemical and Drug Induced Liver Injury; Drug Design; Drug Labeling; Drug-Related Side Effects and Adverse Reactions; Humans; Pharmaceutical Preparations; Reproducibility of Results; United States; United States Food and Drug Administration | 2011 |
Predicting phenolic acid absorption in Caco-2 cells: a theoretical permeability model and mechanistic study.
Topics: Artificial Intelligence; Caco-2 Cells; Cell Membrane Permeability; Cinnamates; Enterocytes; Humans; Hydrophobic and Hydrophilic Interactions; Intestinal Absorption; Kinetics; Models, Biological; Molecular Conformation; Osmolar Concentration; Phenols | 2012 |
Classification of inhibitors of hepatic organic anion transporting polypeptides (OATPs): influence of protein expression on drug-drug interactions.
Topics: Atorvastatin; Biological Transport; Drug Interactions; Estradiol; Estrone; HEK293 Cells; Heptanoic Acids; Humans; Hydroxymethylglutaryl-CoA Reductase Inhibitors; In Vitro Techniques; Least-Squares Analysis; Liver; Liver-Specific Organic Anion Transporter 1; Models, Molecular; Multivariate Analysis; Organic Anion Transporters; Organic Anion Transporters, Sodium-Independent; Protein Isoforms; Pyrroles; Solute Carrier Organic Anion Transporter Family Member 1B3; Structure-Activity Relationship; Transfection | 2012 |
Predictive model for L-type channel inhibition: multichannel block in QT prolongation risk assessment.
Topics: Artificial Intelligence; Calcium Channel Blockers; Calcium Channels, L-Type; Cell Line; Computational Biology; Computer Simulation; Drugs, Investigational; Ether-A-Go-Go Potassium Channels; Expert Systems; Heart Rate; Humans; Models, Biological; Myocytes, Cardiac; NAV1.5 Voltage-Gated Sodium Channel; Potassium Channel Blockers; Quantitative Structure-Activity Relationship; Risk Assessment; Shaker Superfamily of Potassium Channels; Torsades de Pointes; Voltage-Gated Sodium Channel Blockers | 2012 |
MICE models: superior to the HERG model in predicting Torsade de Pointes.
Topics: ERG1 Potassium Channel; Ether-A-Go-Go Potassium Channels; Humans; Models, Theoretical; Patch-Clamp Techniques; Predictive Value of Tests; Torsades de Pointes | 2013 |
A highly predictive 3D-QSAR model for binding to the voltage-gated sodium channel: design of potent new ligands.
Topics: Ligands; Models, Molecular; Quantitative Structure-Activity Relationship; Voltage-Gated Sodium Channels | 2014 |
The antitubercular activity of various nitro(triazole/imidazole)-based compounds.
Topics: Animals; Antitubercular Agents; Cell Line; Chlorocebus aethiops; Dose-Response Relationship, Drug; Humans; Imidazoles; Macrophages; Mice; Microbial Sensitivity Tests; Molecular Structure; Mycobacterium tuberculosis; Nitro Compounds; Structure-Activity Relationship; Triazoles | 2017 |
[Drug therapy of tachyarrhythmias (author's transl)].
Topics: Action Potentials; Adrenergic beta-Antagonists; Ajmaline; Amiodarone; Anti-Arrhythmia Agents; Aprindine; Calcium; Disopyramide; Electrophysiology; Humans; Lidocaine; Mexiletine; Myocardial Infarction; Phenytoin; Procainamide; Quinidine; Tachycardia; Verapamil | 1978 |
The treatment of supraventricular arrhythmias.
Topics: Adrenergic beta-Antagonists; Ajmaline; Amiodarone; Anti-Arrhythmia Agents; Arrhythmia, Sinus; Arrhythmias, Cardiac; Atrial Fibrillation; Atrial Flutter; Cardiac Pacing, Artificial; Digoxin; Disopyramide; Electric Countershock; Humans; Phenytoin; Procainamide; Quinidine; Tachycardia; Tachycardia, Paroxysmal; Verapamil | 1979 |
["Torsades de pointe" and reentry induced by anti-arrhythmia agents].
Topics: Adrenergic beta-Antagonists; Amiodarone; Anti-Arrhythmia Agents; Arrhythmias, Cardiac; Atrial Flutter; Bretylium Compounds; Cardiac Complexes, Premature; Humans; Phenytoin; Prenylamine; Quinidine; Tachycardia; Ventricular Fibrillation; Verapamil | 1978 |
Effects of phenytoin on the cyclic nucleotide system in the motor nerve terminal.
Topics: Animals; Bucladesine; Calcium Chloride; Cats; Electric Stimulation; Evoked Potentials; Hindlimb; Motor Neurons; Muscle Contraction; Neuromuscular Junction; Nucleotides, Cyclic; Phenytoin; Pyridines; Sodium Fluoride; Tetany; Tetraethylammonium Compounds; Theophylline; Verapamil | 1977 |
[Letter: Paroxysmal supraventricular and ventricular tachycardia].
Topics: Adrenergic beta-Antagonists; Aprindine; Heart Ventricles; Humans; Lidocaine; Phenytoin; Quinidine; Tachycardia, Paroxysmal; Time Factors; Verapamil | 1975 |
[New aspects concerning drug therapy of arrhythmia].
Topics: Adrenergic beta-Agonists; Adrenergic beta-Antagonists; Ajmaline; Arrhythmias, Cardiac; Autonomic Nervous System; Bretylium Compounds; Humans; Lidocaine; Membrane Potentials; Parasympatholytics; Parasympathomimetics; Phenytoin; Procainamide; Quinidine; Verapamil | 1975 |
Effects of ionophores A23187 and X537A on vascular smooth muscle activity.
Topics: Animals; Anti-Bacterial Agents; Blood Vessels; Calcimycin; Coronary Vessels; Dogs; Drug Interactions; In Vitro Techniques; Lasalocid; Muscle Contraction; Muscle, Smooth; Norepinephrine; Phenytoin; Potassium Chloride; Time Factors; Verapamil | 1978 |
Antiarrhythmic drugs: clinical pharmacology and therapeutic uses.
Topics: Acebutolol; Amiodarone; Anti-Arrhythmia Agents; Aprindine; Arrhythmias, Cardiac; Bretylium Compounds; Digitalis Glycosides; Disopyramide; Humans; Kinetics; Lidocaine; Mexiletine; Oxytocin; Phenytoin; Procainamide; Propranolol; Quinidine; Verapamil | 1978 |
[Myocardial excitability under the influence of digitalis glycosides and anti-arrhythmia agent].
Topics: Ajmaline; Anti-Arrhythmia Agents; Digitalis Glycosides; Digoxin; Heart Conduction System; Humans; Lidocaine; Myocardial Contraction; Phenytoin; Procainamide; Propranolol; Refractory Period, Electrophysiological; Stimulation, Chemical; Verapamil | 1977 |
[The influence of antiarrhythmic drugs on the exercise-ecg (author's transl)].
Topics: Adult; Ajmaline; Anti-Arrhythmia Agents; Blood Pressure; Electrocardiography; Exercise Test; Heart Rate; Humans; Methods; Phenytoin; Propranolol; Quinidine; Verapamil | 1977 |
[Sino-atrial conduction time].
Topics: Ajmaline; Disopyramide; Heart Conduction System; Humans; Phenytoin; Quinidine; Time Factors; Verapamil | 1977 |
[Influence of cardiac agents on the diastolic irritability of the ventricular myocardium. Consequences for pacemaker therapy].
Topics: Adult; Aged; Ajmaline; Animals; Anti-Arrhythmia Agents; Digitalis Glycosides; Dogs; Female; Heart Rate; Heart Ventricles; Humans; Lidocaine; Male; Middle Aged; Myocardial Contraction; Pacemaker, Artificial; Phenytoin; Procainamide; Propranolol; Stimulation, Chemical; Verapamil | 1976 |
Calcium uptake into rat pheochromocytoma cells.
Topics: Animals; Calcium; Catecholamines; Drug Interactions; In Vitro Techniques; Phenytoin; Pheochromocytoma; Potassium; Rats; Time Factors; Verapamil | 1976 |
Mechanism of action of antidysrhythmic drugs on ventricular conduction as studied with intramural electrodes.
Topics: Ajmaline; Animals; Disopyramide; Dogs; Electrocardiography; Heart Conduction System; Hydroxyzine; Lidocaine; Oxprenolol; Phenytoin; Propranolol; Purkinje Fibers; Quinidine; Verapamil | 1975 |
[Treatment of arrhythmia in general practice].
Topics: Ajmaline; Anti-Arrhythmia Agents; Aprindine; Arrhythmia, Sinus; Arrhythmias, Cardiac; Bradycardia; Humans; Isoproterenol; Lidocaine; Myocardial Infarction; Pacemaker, Artificial; Phenytoin; Procainamide; Propranolol; Quinidine; Tachycardia; Verapamil | 1975 |
Electrophysiologic properties of antidysrhythmic drugs as a rational basis for therapy.
Topics: Anti-Arrhythmia Agents; Arrhythmias, Cardiac; Bretylium Compounds; Hemodynamics; Humans; Lidocaine; Osmolar Concentration; Phenytoin; Procainamide; Propranolol; Quinidine; Verapamil | 1976 |
Effects of Ca2+ antagonists and antiepileptics on tetrodotoxin-sensitive Ca(2+)-conducting channels in isolated rat hippocampal CA1 neurons.
Topics: Animals; Anticonvulsants; Calcium; Calcium Channel Blockers; Calcium Channels; Cells, Cultured; Diltiazem; Dizocilpine Maleate; Dose-Response Relationship, Drug; Flunarizine; Hippocampus; Kinetics; Neurons; Nicardipine; Phenobarbital; Phenytoin; Pyramidal Tracts; Rats; Rats, Wistar; Sodium; Tetrodotoxin; Valproic Acid; Verapamil | 1992 |
Effects of some calcium antagonists upon the activity of common antiepileptic compounds on sound-induced seizures in DBA/2 mice.
Topics: 3-Pyridinecarboxylic acid, 1,4-dihydro-2,6-dimethyl-5-nitro-4-(2-(trifluoromethyl)phenyl)-, Methyl ester; Animals; Anticonvulsants; Body Temperature; Calcium Channel Blockers; Diltiazem; Drug Synergism; Flunarizine; Mice; Mice, Inbred DBA; Nimodipine; Phenobarbital; Phenytoin; Seizures; Valproic Acid; Verapamil | 1992 |
A reduction in verapamil concentrations with phenytoin.
Topics: Adult; Cardiomyopathy, Hypertrophic; Drug Interactions; Epilepsy; Female; Humans; Phenytoin; Verapamil | 1991 |
Involvement of calmodulin in depolarization-induced release of corticotrophin-releasing hormone-41 from the rat hypothalamus in vitro.
Topics: Animals; Calcimycin; Calcium; Calmodulin; Corticotropin-Releasing Hormone; Dose-Response Relationship, Drug; Hypothalamus; In Vitro Techniques; Membrane Potentials; Phenytoin; Potassium Chloride; Radioimmunoassay; Rats; Trifluoperazine; Verapamil; Veratridine | 1991 |
Interactions between calcium channel blockers and the anticonvulsants carbamazepine and phenytoin.
Topics: Aged; Angina Pectoris; Calcium Channel Blockers; Carbamazepine; Diltiazem; Drug Interactions; Female; Humans; Male; Middle Aged; Nifedipine; Phenytoin; Retrospective Studies; Seizures; Verapamil | 1991 |
Participation of transient-type Ca2+ channels in the sustained increase of Ca2+ level in GH3 cells.
Topics: Animals; Calcium; Calcium Channel Blockers; Calcium Channels; Electric Conductivity; In Vitro Techniques; Membrane Potentials; Nickel; Nifedipine; omega-Conotoxin GVIA; Peptides, Cyclic; Phenytoin; Pituitary Gland; Rats; Thyrotropin-Releasing Hormone; Tumor Cells, Cultured; Verapamil | 1990 |
Influence of protective drugs on the EEG during short-term transient ischaemia.
Topics: Animals; Dogs; Electroencephalography; Ischemic Attack, Transient; Lidocaine; Phenytoin; Piracetam; Pyridoxine; Thiopental; Verapamil | 1990 |
Mechanism of calcium channel inhibition by phenytoin: comparison with classical calcium channel antagonists.
Topics: Adrenal Gland Neoplasms; Animals; Binding Sites; Calcium; Calcium Channel Blockers; Carbachol; Cell Line; Cinnarizine; Diltiazem; Flunarizine; Ion Channels; Nicotinic Acids; Nifedipine; Nimodipine; Nitrendipine; Phenytoin; Pheochromocytoma; Potassium; Rats; Sodium; Verapamil | 1985 |
Inhibition of electrically induced seizures by a dihydropyridine calcium channel blocker.
Topics: Animals; Catheterization; Cerebral Cortex; Dose-Response Relationship, Drug; Electric Stimulation; Injections, Intra-Arterial; Ion Channels; Nimodipine; Phenytoin; Rabbits; Seizures; Verapamil | 1986 |
Effects of calcium channel blocking agents on neostigmine-induced fasciculations.
Topics: Animals; Calcium Channel Blockers; Electric Stimulation; Facial Muscles; Fasciculation; Male; Neostigmine; Nerve Endings; Nifedipine; Nitrendipine; Phenytoin; Rats; Rats, Inbred Strains; Verapamil | 1989 |
Management of oesophageal stenosis in epidermolysis bullosa dystrophica.
Topics: Adolescent; Adrenal Cortex Hormones; Child; Child, Preschool; Deglutition Disorders; Dilatation; Epidermolysis Bullosa; Esophageal Stenosis; Female; Humans; Male; Phenytoin; Verapamil | 1989 |
Update on rifampin drug interactions.
Topics: Adrenergic beta-Antagonists; Cyclosporins; Digoxin; Drug Interactions; Humans; Ketoconazole; Phenytoin; Rifampin; Theophylline; Verapamil | 1987 |
Diphenylhydantoin inhibits parathyroid hormone and prostaglandin E2-stimulated bone resorption in mouse calvaria without affecting cyclic AMP formation.
Topics: Animals; Bone Resorption; Calcium; Cyclic AMP; Dinoprostone; Dose-Response Relationship, Drug; Glycoside Hydrolases; Mice; Parathyroid Hormone; Phenytoin; Prostaglandins E; Skull; Time Factors; Tritium; Verapamil | 1985 |
Medical treatment for inoperable insulinoma: clinical usefulness of diphenylhydantoin and diltiazem.
Topics: Adenoma, Islet Cell; Aged; Benzazepines; Blood Glucose; C-Peptide; Celiac Artery; Diltiazem; Female; Humans; Insulin; Insulinoma; Pancreatic Neoplasms; Phenytoin; Propranolol; Radiography; Verapamil | 1986 |
Effect of dihydropyridines and diphenylalkylamines on pentylenetetrazol-induced seizures and cerebral blood flow in cats.
Topics: Animals; Anticonvulsants; Brain; Calcium Channel Blockers; Cats; Cerebrovascular Circulation; Clonazepam; Electroencephalography; Female; Male; Nimodipine; Pentylenetetrazole; Phenytoin; Seizures; Verapamil | 1987 |
Effects of antiarrhythmic agents on isoproterenol-induced ventricular fibrillation in heavy rats: a possible model of sudden cardiac death.
Topics: Animals; Anti-Arrhythmia Agents; Body Weight; Bretylium Tosylate; Death, Sudden; Disease Models, Animal; Electrocardiography; Isoproterenol; Male; Niacin; Phenytoin; Procainamide; Propranolol; Quaternary Ammonium Compounds; Quinidine; Rats; Ventricular Fibrillation; Verapamil | 1986 |
Cardiovascular and respiratory effects of antiarrhythmic drugs on conscious beagles.
Topics: Animals; Anti-Arrhythmia Agents; Blood Pressure; Disopyramide; Dogs; Dose-Response Relationship, Drug; Heart Rate; Hemodynamics; Lidocaine; Male; Phenytoin; Procainamide; Respiration; Verapamil | 1985 |
[Hypertrophic gingivitis caused by verapamil].
Topics: Angina Pectoris; Gingivitis; Humans; Hyperplasia; Male; Middle Aged; Phenytoin; Verapamil | 1985 |
[Poisoning by tricyclic antidepressants and antidotes].
Topics: Adolescent; Amitriptyline; Female; Humans; Phenytoin; Physostigmine; Seizures; Suicide, Attempted; Tachycardia; Verapamil | 1985 |
[What is assured in the treatment of heart arrhythmia?].
Topics: Adrenergic beta-Antagonists; Ajmaline; Atrial Fibrillation; Atrial Flutter; Atropine; Bradycardia; Cardiac Complexes, Premature; Heart Block; Humans; Lidocaine; Metaproterenol; Phenytoin; Procainamide; Quinidine; Tachycardia; Verapamil | 1972 |
[Therapy of arrhythmias].
Topics: Ajmaline; Arrhythmias, Cardiac; Atrial Fibrillation; Bradycardia; Caffeine; Cardiac Complexes, Premature; Digitalis Glycosides; Heart Block; Humans; Lidocaine; Metaproterenol; Phenytoin; Procainamide; Tachycardia; Ventricular Fibrillation; Verapamil | 1973 |
[Modern therapy of cardiac arrhythmias].
Topics: Adrenergic beta-Antagonists; Ajmaline; Anti-Arrhythmia Agents; Arrhythmias, Cardiac; Atropine; Bradycardia; Humans; Lidocaine; Metaproterenol; Phenytoin; Procainamide; Quinidine; Tachycardia; Verapamil | 1973 |
[The treatment of cardiac arrhythmias: complexity and schematization].
Topics: Adrenergic beta-Antagonists; Anti-Arrhythmia Agents; Arrhythmias, Cardiac; Atrial Fibrillation; Atrial Flutter; Benzofurans; Digitalis Glycosides; Electric Countershock; Lidocaine; Phenytoin; Potassium; Procainamide; Quinidine; Tachycardia; Verapamil | 1973 |
[Effect of anti-arrhythmic drugs on intracardiac conduction (His-bundle electrogram) and sinus-node automatism in man].
Topics: Acetanilides; Adrenergic beta-Antagonists; Ajmaline; Amino Alcohols; Anti-Arrhythmia Agents; Atrial Fibrillation; Heart Block; Heart Conduction System; Humans; Middle Aged; Phenytoin; Propylamines; Sinoatrial Node; Verapamil; Wolff-Parkinson-White Syndrome | 1973 |
[Therapy of arrhythmia in children].
Topics: Arrhythmias, Cardiac; Cardiac Complexes, Premature; Child; Humans; Male; Phenytoin; Phytotherapy; Plants, Medicinal; Propranolol; Rauwolfia; Sparteine; Tachycardia; Verapamil | 1969 |
[Influence of active antiarrhythmia substances on refractory period and contractility of guinea pig atria].
Topics: Animals; Anti-Arrhythmia Agents; Guinea Pigs; Heart; Heart Atria; In Vitro Techniques; Lidocaine; Muscle Contraction; Nitriles; Phenytoin; Plants, Medicinal; Procainamide; Quinidine; Rauwolfia; Reaction Time; Sparteine; Vasodilator Agents; Verapamil | 1969 |
Actions of antiarrhythmic drugs on refractory period and contractility of isolated rat and guinea-pig atria.
Topics: Ajmaline; Animals; Anti-Arrhythmia Agents; Ethers; Ethylamines; Glycerol; Guinea Pigs; Heart Atria; Lidocaine; Male; Muscle Contraction; Phenytoin; Procainamide; Propranolol; Quinidine; Rats; Sparteine; Verapamil | 1971 |
[What is certain in the therapy of heart diseases?].
Topics: Adrenergic beta-Antagonists; Anti-Arrhythmia Agents; Arrhythmias, Cardiac; Cardiac Output; Digitalis Glycosides; Drug Hypersensitivity; Endocarditis, Bacterial; Heart Diseases; Humans; Penicillins; Phenytoin; Procainamide; Propranolol; Rheumatic Heart Disease; Verapamil | 1969 |
[Clinical pharmacology and adverse effects of various anti-arrhythmic drugs].
Topics: Adrenergic beta-Antagonists; Aged; Anti-Arrhythmia Agents; Bone Marrow Diseases; Central Nervous System Diseases; Female; Gastrointestinal Diseases; Heart Diseases; Hemodynamics; Humans; Imidazoles; Isoproterenol; Lidocaine; Membrane Potentials; Phenytoin; Plants, Medicinal; Procainamide; Quinidine; Rauwolfia; Verapamil | 1971 |
[Action of antiarrhythmic and -receptor blocking drugs on functional refractory period and contractility of electrically stimulated guinea-pig atria].
Topics: Adrenergic beta-Antagonists; Alprenolol; Animals; Anti-Arrhythmia Agents; Atrial Function; Drug Interactions; Electric Stimulation; Guinea Pigs; Male; Muscle Contraction; Phenytoin; Procainamide; Propranolol; Quinidine; Reserpine; Sparteine; Sympatholytics; Time Factors; Verapamil | 1971 |
[Action of anti-arrhythmia agents on intracardiac conduction].
Topics: Ajmaline; Aniline Compounds; Animals; Anti-Arrhythmia Agents; Benzofurans; Bundle of His; Cardiac Catheterization; Depression, Chemical; Diethylamines; Dogs; Electrocardiography; Heart Conduction System; Indans; Iodobenzoates; Lidocaine; Lidoflazine; Phenytoin; Procainamide; Propranolol; Quinidine; Verapamil | 1974 |
Action of antiarrhythmic drugs on His bundle electrogram and sinus node function.
Topics: Action Potentials; Ajmaline; Aniline Compounds; Anti-Arrhythmia Agents; Benzyl Compounds; Bundle of His; Cardiac Catheterization; Diethylamines; Electrocardiography; Heart Block; Heart Conduction System; Heart Rate; Humans; Imidazoles; Indans; Phenytoin; Practolol; Sinoatrial Node; Sparteine; Verapamil | 1974 |
Experimental evaluation of antiarrhythmic drugs in the guinea pig.
Topics: Aconitum; Ajmaline; Animals; Anti-Arrhythmia Agents; Arrhythmias, Cardiac; Bretylium Compounds; Guinea Pigs; Lidocaine; Phenytoin; Procainamide; Propranolol; Quinidine; Strophanthins; Verapamil | 1973 |
[Effect of antiarrhythmics on intracardial excitation conduction in His-bundle electrography].
Topics: Ajmaline; Anti-Arrhythmia Agents; Heart Conduction System; Humans; Phenytoin; Practolol; Verapamil | 1973 |
[The problems of paroxysmal auricular flutter with atrio-ventricular block (author's transl)].
Topics: Aged; Diagnosis, Differential; Digitalis Glycosides; Electrocardiography; Heart Block; Humans; Male; Phenytoin; Potassium; Propranolol; Tachycardia, Paroxysmal; Verapamil | 1973 |
[Disturbances of cardiac rhythm and their treatment].
Topics: Adult; Aged; Ajmaline; Arrhythmias, Cardiac; Digitoxin; Digoxin; Humans; Lidocaine; Metaproterenol; Middle Aged; Phenytoin; Procainamide; Quinidine; Reserpine; Verapamil | 1970 |
[Differential therapy of tachycardial arrhythmias].
Topics: Anti-Arrhythmia Agents; Humans; Lidocaine; Metaproterenol; Phenytoin; Procainamide; Quinidine; Reserpine; Sparteine; Sympatholytics; Tachycardia; Tachycardia, Paroxysmal; Verapamil | 1969 |
Management of cardiac drug overdose.
Topics: Adrenergic beta-Antagonists; Amiodarone; Anti-Arrhythmia Agents; Digoxin; Disopyramide; Humans; Phenytoin; Poison Control Centers; Verapamil | 1984 |
Effect of trifluoperazine, D600, and phenytoin on depolarization- and thyrotropin-releasing hormone-induced thyrotropin release from rat pituitary tissue.
Topics: Animals; Calcium; Gallopamil; Ion Channels; Male; Membrane Potentials; Phenytoin; Pituitary Gland, Anterior; Potassium; Rats; Sodium; Thyrotropin; Thyrotropin-Releasing Hormone; Trifluoperazine; Verapamil; Veratridine | 1981 |
[Quinidine interactions with propranolol, phenytoin, verapamil and procainamide].
Topics: Arrhythmias, Cardiac; Drug Interactions; Drug Therapy, Combination; Female; Half-Life; Humans; Male; Middle Aged; Phenytoin; Procainamide; Propranolol; Quinidine; Verapamil | 1984 |
Quantitative analysis of the antiarrhythmic effect of drugs on canine ventricular arrhythmias by the determination of minimum effective plasma concentrations.
Topics: Animals; Anti-Arrhythmia Agents; Aprindine; Arrhythmias, Cardiac; Disopyramide; Dogs; Female; Lidocaine; Male; Mexiletine; Phenytoin; Verapamil | 1983 |
[Emergency therapy of cardiac arrhythmias. Statistico-clinical evaluation of verapamil (clinical note)].
Topics: Acute Disease; Adult; Aged; Ajmaline; Arrhythmias, Cardiac; Bunaftine; Female; Humans; Lidocaine; Male; Middle Aged; Phenytoin; Verapamil | 1982 |
Canine-effective plasma concentrations of antiarrhythmic drugs on the two-stage coronary ligation arrhythmia.
Topics: Animals; Anti-Arrhythmia Agents; Arrhythmias, Cardiac; Coronary Vessels; Disopyramide; Dogs; Dose-Response Relationship, Drug; Isoquinolines; Lidocaine; Ligation; Phenytoin; Propanolamines; Verapamil | 1982 |
Some further observations on the stimulation by high external potassium of the sodium efflux in barnacle muscle fibers.
Topics: Animals; Chelating Agents; Fluorides; Imipramine; Muscles; Phenothiazines; Phenytoin; Potassium; Purine Nucleotides; Sodium; Stimulation, Chemical; Thoracica; Verapamil | 1982 |
Advances in the diagnosis and treatment of tachydysrhythmias in children.
Topics: Ambulatory Care; Atrioventricular Node; Bundle of His; Child; Dose-Response Relationship, Drug; Electrocardiography; Exercise Test; Humans; Pacemaker, Artificial; Phenytoin; Propranolol; Tachycardia; Telephone; Ventricular Fibrillation; Verapamil; Wolff-Parkinson-White Syndrome | 1981 |
Mechanism of grayanotoxin III-induced afterpotentials in feline cardiac Purkinje fibers.
Topics: Animals; Calcium; Cats; Diterpenes; Electric Stimulation; Female; Heart Conduction System; In Vitro Techniques; Male; Membrane Potentials; Phenytoin; Potassium; Purkinje Fibers; Verapamil | 1981 |
Nifedipine for digitalis-induced arrhythmias.
Topics: Animals; Arrhythmias, Cardiac; Dogs; Nifedipine; Phenytoin; Pyridines; Strophanthins; Verapamil | 1980 |
Inhibitory effect of calcium channel blockers on growth of pancreatic cancer cells.
Topics: Calcium Channel Blockers; Cell Division; Humans; Pancreatic Neoplasms; Phenytoin; Tumor Cells, Cultured; Verapamil | 1994 |
Modulators and substrates of P-glycoprotein and cytochrome P4503A coordinately up-regulate these proteins in human colon carcinoma cells.
Topics: Adenocarcinoma; ATP Binding Cassette Transporter, Subfamily B, Member 1; Base Sequence; Blotting, Northern; Cell Line; Clotrimazole; Colonic Neoplasms; Cytochrome P-450 CYP2E1; Cytochrome P-450 Enzyme System; Dexamethasone; DNA Primers; Doxorubicin; Gene Expression Regulation, Neoplastic; Humans; Midazolam; Mixed Function Oxygenases; Molecular Sequence Data; Multigene Family; Phenobarbital; Phenytoin; Polymerase Chain Reaction; Rifampin; Tumor Cells, Cultured; Verapamil | 1996 |
Familial polymorphic ventricular arrhythmias: a quarter century of successful medical treatment based on serial exercise-pharmacologic testing.
Topics: Adolescent; Adrenergic beta-Agonists; Adrenergic beta-Antagonists; Adult; Anti-Arrhythmia Agents; Anticonvulsants; Catecholamines; Child; Drug Administration Routes; Echocardiography; Electrocardiography, Ambulatory; Exercise Test; Female; Follow-Up Studies; Heart Ventricles; Humans; Isoproterenol; Male; Middle Aged; Pedigree; Phenytoin; Propranolol; Retrospective Studies; Tachycardia, Ventricular; Treatment Outcome; Verapamil | 1999 |
Different transporters for tri-iodothyronine (T(3)) and thyroxine (T(4)) in the human choriocarcinoma cell line, JAR.
Topics: Analysis of Variance; Biological Transport; Calcium Channel Blockers; Choriocarcinoma; Cyclooxygenase Inhibitors; Diazepam; Female; GABA Modulators; Humans; Iodine Radioisotopes; Leucine; Meclofenamic Acid; Mefenamic Acid; Nifedipine; Nitrendipine; Phenylalanine; Phenytoin; Thyroxine; Triiodothyronine; Tryptophan; Tumor Cells, Cultured; Uterine Neoplasms; Verapamil | 2000 |
Comparative study of calcium-channel blockers on cell proliferation, DNA and collagen syntheses, and EGF receptors of cultured gingival fibroblasts derived from human nifedipine, nicardipine and nisoldipine responders.
Topics: Adult; Aged; Analysis of Variance; Anticonvulsants; Calcium Channel Blockers; Cell Culture Techniques; Cell Division; Collagen; Diltiazem; DNA; ErbB Receptors; Female; Fibroblasts; Flow Cytometry; Gingiva; Gingival Overgrowth; Humans; Male; Middle Aged; Nicardipine; Nifedipine; Nisoldipine; Phenytoin; Radiopharmaceuticals; Statistics as Topic; Tritium; Verapamil | 2001 |
Increased P-glycoprotein function and level after long-term exposure of four antiepileptic drugs to rat brain microvascular endothelial cells in vitro.
Topics: Animals; Anticonvulsants; ATP Binding Cassette Transporter, Subfamily B, Member 1; Blood-Brain Barrier; Brain; Carbamazepine; Cells, Cultured; Cerebral Arteries; Cyclosporine; Dose-Response Relationship, Drug; Drug Administration Schedule; Endothelial Cells; Immunosuppressive Agents; Indicators and Reagents; Microcirculation; Phenobarbital; Phenytoin; Rats; Rhodamine 123; Sodium Channel Blockers; Time; Up-Regulation; Valproic Acid; Verapamil | 2008 |
In vitro concentration dependent transport of phenytoin and phenobarbital, but not ethosuximide, by human P-glycoprotein.
Topics: Anticonvulsants; ATP Binding Cassette Transporter, Subfamily B, Member 1; Biological Transport, Active; Blood-Brain Barrier; Calcium Channel Blockers; Cell Line; Dose-Response Relationship, Drug; Ethosuximide; Humans; In Vitro Techniques; Phenobarbital; Phenytoin; Rhodamine 123; Verapamil | 2010 |
Study on in situ and in vivo absorption kinetics of phenytoin by modulating P-glycoprotein with verapamil in rats.
Topics: Administration, Oral; Animals; Anticonvulsants; ATP Binding Cassette Transporter, Subfamily B, Member 1; Chromatography, High Pressure Liquid; Ileum; Intestinal Absorption; Male; Perfusion; Permeability; Phenytoin; Propranolol; Rats; Rats, Wistar; Verapamil | 2011 |
Effects of high frequency electrical stimulation and R-verapamil on seizure susceptibility and glutamate and GABA release in a model of phenytoin-resistant seizures.
Topics: Animals; Disease Models, Animal; Disease Susceptibility; Drug Resistance; Electric Stimulation; Extracellular Fluid; gamma-Aminobutyric Acid; Glutamic Acid; Male; Phenytoin; Rats; Rats, Wistar; Seizures; Stereoisomerism; Verapamil | 2011 |
[Effect of anti-arrhythmia drugs on mouse arrhythmia induced by Bufonis Venenum].
Topics: Amiodarone; Animals; Anti-Arrhythmia Agents; Arrhythmias, Cardiac; Bufanolides; Electrocardiography; Female; Heart Rate; In Vitro Techniques; Lethal Dose 50; Lidocaine; Male; Mice; Phenytoin; Propranolol; Verapamil | 2011 |
Verapamil effect on phenytoin pharmacokinetics in rats.
Topics: Animals; Anticonvulsants; Blood-Brain Barrier; Drug Interactions; Female; Phenytoin; Rats; Rats, Sprague-Dawley; Verapamil | 2013 |
P-glycoprotein alters blood-brain barrier penetration of antiepileptic drugs in rats with medically intractable epilepsy.
Topics: Animals; Anticonvulsants; ATP Binding Cassette Transporter, Subfamily B, Member 1; Blood-Brain Barrier; Brain; Carbamazepine; Disease Models, Animal; Drug Resistance; Epilepsy; Male; Phenytoin; Rats; Rats, Sprague-Dawley; RNA, Messenger; Tissue Distribution; Up-Regulation; Verapamil | 2013 |
Pharmacoproteomics-based reconstruction of in vivo P-glycoprotein function at blood-brain barrier and brain distribution of substrate verapamil in pentylenetetrazole-kindled epilepsy, spontaneous epilepsy, and phenytoin treatment models.
Topics: Animals; Anticonvulsants; ATP Binding Cassette Transporter, Subfamily B, Member 1; Blood-Brain Barrier; Brain; Disease Models, Animal; Epilepsy; Male; Membrane Proteins; Mice; Pentylenetetrazole; Phenytoin; Proteomics; Verapamil | 2014 |
Reversal of P-glycoprotein overexpression by Ginkgo biloba extract in the brains of pentylenetetrazole-kindled and phenytoin-treated mice.
Topics: Animals; ATP Binding Cassette Transporter, Subfamily B, Member 1; Brain; Caspase 3; Disease Models, Animal; Ginkgo biloba; Kindling, Neurologic; Male; Mice; Pentylenetetrazole; Phenytoin; Plant Extracts; Seizures; Verapamil | 2015 |
Silymarin as a flavonoid-type P-glycoprotein inhibitor with impact on the pharmacokinetics of carbamazepine, oxcarbazepine and phenytoin in rats.
Topics: Animals; Anticonvulsants; ATP Binding Cassette Transporter, Subfamily B, Member 1; Brain; Carbamazepine; Drug Interactions; Male; Oxcarbazepine; Phenytoin; Rats; Rats, Wistar; Silymarin; Tissue Distribution; Verapamil | 2021 |
Predicted values for human total clearance of a variety of typical compounds with differently humanized-liver mouse plasma data.
Topics: Acetamides; Albuterol; Animals; Carbamates; Chromatography, Liquid; Diazepam; Diclofenac; Digitoxin; Humans; Itraconazole; Ketoprofen; Liver; Metabolic Clearance Rate; Mice; Mice, Transgenic; Naproxen; Pharmaceutical Preparations; Phenytoin; Piperidines; Pravastatin; Pyrimidines; Quinidine; Tandem Mass Spectrometry; Telmisartan; Terfenadine; Verapamil | 2020 |